Single Shot Versus Continuous Adductor Canal Block in Patients Undergoing Total Knee Arthroplasty
Comparison Between the Analgesic Effects of Single Shot Versus Continuous Adductor Canal Block in Patients Undergoing Total Knee Arthroplasty
1 other identifier
interventional
60
1 country
2
Brief Summary
Adductor canal block (ACB) has emerged as an option for postoperative regional analgesia in patients undergoing total knee arthroplasty (TKA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2017
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2018
CompletedFirst Submitted
Initial submission to the registry
June 30, 2021
CompletedFirst Posted
Study publicly available on registry
August 3, 2021
CompletedAugust 4, 2021
August 1, 2021
1 year
June 30, 2021
August 3, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
postoperative pain scores by visual analogue score
visual analogue score is a straight, vertical 10-cm line with the bottom point representing "no pain" = (0cm) and the top point representing "the worst pain you could ever have" = (10 cm).
48 hours
Secondary Outcomes (3)
time to up and go test (minutes)
48 hours
six-minute walking test
48 hours
the 30-Second Chair test
48 hours
Study Arms (2)
Single shot adductor canal block
ACTIVE COMPARATORFollowing sterile preparation and draping, an ultrasound survey of the medial thigh was performed, halfway between the superior anterior iliac spine and the patella. The superficial femoral artery has been identified beneath the sartorius muscle in a short-axis view, with the vein just inferior and the saphenous nerve just lateral to the artery. A 20 Gauge, 120 mm, non-cuttings tip echogenic needle (SonoPlex STIM, Germany) needle was introduced in-plane, and 2 to 3 mL of LA bolus (0.25 % Bupivacaine) was used to confirm proper needle placement in the adductor canal near the saphenous nerve. Then, a bolus of 20 ml of Bupivacaine 0.25 % was injected through the needle
Continuous adductor canal block
ACTIVE COMPARATORa catheter was secured in place using Tegaderm. The catheters were connected to a pump that infused local anesthetic, 20 mL of 0.25 % bupivacaine, followed by 48 hours of continuous infusion of 0.125 % bupivacaine at 5 mL/h.
Interventions
An ultrasound machine (Philips; Model: OTD020, AcBel Polytech Inc., Taiwan) with a 5-10 MHz linear probe was used to perform the adductor canal block immediately postoperatively.
Eligibility Criteria
You may qualify if:
- Patients scheduled for primary total knee arthroplasty with
- American Society of Anesthesiologists (ASA) physical status I -III,
- mentally competent and able to give consent for enrollment in the study.
You may not qualify if:
- Patient younger than 18 years old or older than 70 years old
- Allergy to local anesthetics, systemic opioids (fentanyl, morphine, hydromorphone, and any of the drugs included in the multimodal perioperative pain protocol.
- Revision surgeries were excluded.
- Impaired kidney functions and patients with coagulopathy were also excluded.
- Chronic pain syndromes and patients with chronic opioid use defined as the use of regular daily doses of systemic narcotics for the past 6 months prior to the surgery.
- BMI of 40 or more
- Pregnancy (positive urine pregnancy test result in Preop area on the morning of surgery)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Aswan University Hospital
Aswān, 81511, Egypt
Huda Fahmy
Aswān, 81511, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- A computer-generated randomization table will be used for patient allocation to one of the two study groups, The SACB group, and the CACB group. Randomization was done in blocks of 10 patients each. Patients' assignments were written in a sealed envelope that was only open after the patient consents to the study.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor of Anesthesia and Intensive Care
Study Record Dates
First Submitted
June 30, 2021
First Posted
August 3, 2021
Study Start
March 15, 2017
Primary Completion
March 31, 2018
Study Completion
June 30, 2018
Last Updated
August 4, 2021
Record last verified: 2021-08